Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "sanofi"

Pieris Pharmaceuticals Achieves Payment Milestone in Sanofi Collaboration
Canadian Business Journal

Pieris Pharmaceuticals triggers milestone payment from Sanofi ...

Biotechnology company Pieris Pharmaceuticals (NasdaqCM:PIRS) said on Monday that it expects to receive the third payment-based milestone under its tetraspecific Anticalin R&D collaboration from Sanofi. The undisclosed milestone payment is part of ... Bloomberg, 2 hours ago
Pieris achieves third payment milestone in R&D collaboration with Sanofi Pharmaceutical Business Review, 1 hour ago

261 images for sanofi

The Hindu, 2 days ago, 2 days ago
Fidelity Brokerage Services LLC, 3 days ago
Dubai PR Network, 1 day ago
Yahoo! News Australia, 3 days ago
Business Insider, 3 days ago
Place North West, 3 days ago
NDTV Profit, 3 days ago
American Banking News - Forex, 1 week ago
Reuters, 3 days ago

Sanofi Launches New Priftin® (Rifapentine) Packaging

BRIDGEWATER, N.J. , Dec. 1, 2015 /PRNewswire/ -- Sanofi announced today the launch of a new 24-count tablet pack of Priftin® (rifapentine) for the treatment of latent tuberculosis infection (LTBI) in patients two years of age and older who are at ...
 Barchart13 minutes ago Sanofi Launches New Priftin ® (Rifapentine) Packaging  Stockwatch9 minutes ago SANOFI : Launches New Priftin® (Rifapentine) Packaging  4 Traders11 minutes ago
European Pharmaceutical Review

PTI - SANOFI(Bcm23) - Sanofi Pasteur to launch injectable polio vaccine for infants

SANOFI(Bcm23) - Sanofi Pasteur to launch injectable polio vaccine for infants Contributed by NAMPA / PTI. Mumbai, Nov 30 (PTI) Sanofi Pasteur, the vaccines division of Sanofi, has said that it is launching ShanIPV, an injectable inactivated ...
 Namibia Press Agency1 day ago Sanofi introduces inactivated polio vaccine for Indian infants  MyIris1 day ago BRIEF-Sanofi says polio vaccine ShanIPV soon available in India  Reuters UK1 day ago Sanofi Pasteur's polio vaccine soon to ship to India  European Pharmaceutical Review17 hours ago

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

TARRYTOWN, New York and PARIS, Nov. 24, 2015 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the companies have completed enrollment in the global Phase 3 ODYSSEY OUTCOMES trial, which is ...
 PharmaVOICE18 hours ago Regeneron and Sanofi partnership announces full enrollment of 18,000 patient ODYSSEY OUTCOMES trial of Praluent Injection  Bloomberg6 days ago Sanofi, Regeneron complete enrollment in global phase 3 ODYSSEY OUTCOMES trial of Praluent injection  PharmaBiz6 days ago Sanofi et Regeneron annoncent que le recrutement des 18 000 patients dans l'essai ODYSSEY OUTCOMES de Praluent® (alirocumab) est terminé  Sante Log5 days ago
ACQ Magazine

Sanofi execs working with Lazard on $12B animal health sale or spinoff

Just a couple of weeks ago, Sanofi ( $SNY ) announced that it was mulling options for its animal health unit, Merial , which offered "limited synergies" with the rest of the company. Now, investment bankers at Lazard are running the numbers on a ...
 FiercePharma20 hours ago Sanofi mulls EUR 12bn sale of Merial: Reuters  M&A Portal22 hours ago Investment Bank Works with Sanofi to Unload $12.7 Billion Animal Health Biz  BioSpace23 hours ago LAZARD : Works with sanofi on €12bn animal health unit  4 Traders1 day ago

UnitedHealth Unit Favors Sanofi, Regeneron Cholesterol Drug

UnitedHealth Group Inc.'s Oxford unit, which runs health plans in the northeastern U.S., will favor Sanofi and Regeneron Pharmaceuticals Inc.'s new cholesterol-cutting shot over a similar treatment made by Amgen Inc. Oxford covers about 1.2 ...
 Bloomberg12 hours ago

Sanofi Chipping Away At Biogen's MS Dominance

A n analysis of October sales from IMS Health (NYSE: IMS ) shows that Sanofi (NYSE: SNY ) is continuing to gain market share from Biogen (NASDAQ: BIIB ) in multiple sclerosis, according to RBC Capital Markets. Biogen sold $284 million worth of ...
 Investor's Business Daily21 hours ago

European Pre-Filled Syringes Market: Latest updates from Allergan, Novartis, MHRA, Sanofi R&D, Amgen, GSK, Sandoz

, London): SMi's 8th Annual Conference and Exhibition on Pre-Filled Syringes plays host to key expert speakers from Sanofi R&D, F.Hoffmann-La Rochd Ltd., Amgen and Barts Health Pharmaceuticals London, UK (PRWEB UK) 30 November 2015 SMi Group's ...
 Benzinga.com22 hours ago
Trade Arabia

UAE Ministry of Health and GlobalpharmaA Sanofi Company launch Middle Easts first innovative advanced medicine pack to empower patients

MENAFN Press - 30/11/2015 No. of Ratings : 0 (MENAFN Press) Celebrating the UAE Innovation Week the UAE MOH and Globalpharma -- A Sanofi Company announced the launch of the innovative advanced medicine pack as a result of the consolidated effort ...
 MENAFN1 day ago UAE Ministry launches medicine pack for visually impaired  Trade Arabia1 day ago New medicine packaging to help visually impaired patients in ME  The Gulf Today2 days ago Medicine pack made for visually impaired  Khaleej Times2 days ago

Sanofi Pasteur to start shipment of injectable polio vaccine

MUMBAI: Sanofi Pasteur, the vaccines division of Sanofi, announced that the first shipment of ShanIPV, a new injectable, inactivated polio vaccine (IPV) manufactured by its Hyderabad-based affiliate Shantha Biotechnics will start soon. These first ...
 Times of India1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sanofi
Get updated on latest news & your favorite topics right in your inbox!
More     Less